Abiopharma

🔍 Stillwell Richard Newcomb (Director)

Company: Tonix Pharmaceuticals Holding Corp. (TNXP)

Report Date: 2025-05-13

Detailed Transactions and Holdings:

• Acquired 10,000 shares of Stock Option at $20.18 per share (Derivative)
  Date: 2025-05-13 | Code: A | Expires: 2035-05-13 | Exercise: 2026-05-13 | equity_swap_involved: 0 | shares_owned_after: 10,000.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders.